April 25, 2019 | By CB Insights
Future of Health (Oct. 2-3, NYC) brings together 600 executives from the world’s largest healthcare institutions, most disruptive startups, and most active private equity & venture capital investors. Get your ticket today before prices go up.
There are a lot of bottlenecks throughout clinical trials, which can keep patients from finding or enrolling in the right trials, and keep researchers from sourcing enough eligible patients. Below, we explore the startups looking to disrupt this market and highlight the emerging tech here.
Learn how AI & big tech could make drug development faster, cheaper, and more effective.
Categories: DPC News